• LAST PRICE
    0.5774
  • TODAY'S CHANGE (%)
    Trending Up0.0087 (1.5298%)
  • Bid / Lots
    0.5500/ 2
  • Ask / Lots
    0.5780/ 5
  • Open / Previous Close
    0.5599 / 0.5687
  • Day Range
    Low 0.5500
    High 0.5890
  • 52 Week Range
    Low 0.3601
    High 1.2299
  • Volume
    220,603
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.5644
TimeVolumeORTX
09:32 ET6060.5599
09:33 ET39360.55
09:51 ET16920.571
09:53 ET2000.589
10:02 ET10000.5767
10:08 ET53000.58
10:18 ET2090.58
10:26 ET22000.565
10:33 ET13300.5789
10:36 ET200000.5789
10:38 ET20070.5787
10:42 ET10000.57
10:49 ET1000.578
11:00 ET2000.577
11:02 ET90000.5651
11:03 ET10000.569999
11:09 ET2000.5652
11:12 ET1000.5652
11:27 ET9000.5653
11:34 ET7770.5653
11:43 ET2000.569999
11:52 ET143500.5661
11:56 ET72880.5671
11:57 ET3000.5663
12:14 ET1000.578
12:15 ET30000.578
12:28 ET22000.578
12:30 ET3250.5779
12:42 ET90300.5651
01:09 ET3950.5704
01:13 ET10000.5704
01:15 ET1110.5704
01:24 ET7990.5674
01:26 ET1000.572501
01:29 ET20000.577999
01:33 ET165080.55
01:36 ET577000.55
01:38 ET1000.55
01:40 ET15000.5688
01:44 ET1280.5601
01:45 ET3000.5777
01:49 ET2500.56885
02:14 ET7750.5601
02:25 ET41480.561101
02:34 ET19000.565
02:36 ET44980.5553
02:38 ET47390.55641
03:17 ET13820.56
03:44 ET50000.558
03:53 ET1130.5773
03:55 ET39890.555
03:57 ET27000.5551
04:00 ET119940.5774
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesORTX
Orchard Therapeutics PLC
73.2M
-0.4x
---
United StatesIMAB
I-Mab
494.4M
-1.4x
---
United StatesOCUP
Ocuphire Pharma Inc
72.8M
-3.0x
---
United StatesASPI
ASP Isotopes Inc
62.5M
0.0x
---
United StatesGBLP
Global Pharmatech Inc
55.3M
-2.1x
---
United StatesSEEL
Seelos Therapeutics Inc
90.2M
-1.1x
---
As of 2023-02-04

Company Information

Orchard Therapeutics plc is a gene therapy company. The Company is engaged in development, manufacturing and commercialization of gene and cell therapies to provide curative therapies to patients suffering from a range of diseases. The Company's portfolio includes a commercial-stage product and research and development-stage product candidates. It is focused on severe neurometabolic diseases and early research programs in rare primary immune deficiencies, including OTL-103 for treatment of Wiskott Aldrich syndrome (WAS), OTL-102 for treatment of X-linked chronic granulomatous disease (X-CGD), and Strimvelis for adenosine deaminase severe combined immunodeficiency (ADA-SCID). The Company also develops, OTL-105, an investigational ex vivo autologous HSC gene therapy for the treatment of hereditary angioedema (HAE), a life-threatening rare disorder that causes recurring swelling attacks in the face, throat, extremities and abdomen. It also develops OTL-200 under the brand name Libmeldy.

Contact Information

Headquarters
245 Hammersmith Road, 3Rd FloorLondon, United Kingdom W6 8PW
Phone
203-808-8286
Fax
---

Executives

Non-Executive Independent Chairman of the Board
James Geraghty
President, Chief Operating Officer
Frank Thomas
Chief Executive Officer, Director
Bobby Gaspar
Non-Executive Independent Director
Steven Altschuler
Non-Executive Independent Director
Joanne Beck

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$73.2M
Revenue (TTM)
$16.2M
Shares Outstanding
126.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.86
EPS
$-1.40
Book Value
$1.67
P/E Ratio
-0.4x
Price/Sales (TTM)
4.5
Price/Cash Flow (TTM)
---
Operating Margin
-816.69%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.